HuGE Literature Finder
Records 1-4
|
Clinical significance of tumor mutation burden and DNA damage repair in advanced stage non-small cell lung cancer patients.
European review for medical and pharmacological sciences 2020 Jul 24 (14): 7664-7672. Zhang H, Deng Y-M, Chen Z-C, Tang Y-C, Yang S, Zhang S-D, Liang J-M, Wang Y-G, Wu X, Zhang R-W, Feng W |
|
Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets.
Nature communications 2016 Oct 7 13131. Chen Ying-Bei, Xu Jianing, Skanderup Anders Jacobsen, Dong Yiyu, Brannon A Rose, Wang Lu, Won Helen H, Wang Patricia I, Nanjangud Gouri J, Jungbluth Achim A, Li Wei, Ojeda Virginia, Hakimi A Ari, Voss Martin H, Schultz Nikolaus, Motzer Robert J, Russo Paul, Cheng Emily H, Giancotti Filippo G, Lee William, Berger Michael F, Tickoo Satish K, Reuter Victor E, Hsieh James |
|
USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs.
Lung cancer (Amsterdam, Netherlands) 2016 Jun . Malapelle Umberto, Morra Francesco, Ilardi Gennaro, Visconti Roberta, Merolla Francesco, Cerrato Aniello, Napolitano Virginia, Monaco Roberto, Guggino Gianluca, Monaco Guglielmo, Staibano Stefania, Troncone Giancarlo, Celetti Ange |
|
Evidence that the lung Adenocarcinoma EML4-ALK fusion gene is not caused by exposure to secondhand tobacco smoke during childhood.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2014 Jul 23 (7): 1432-4. Ryan Bríd M, Wang Yi, Jen Jin, Yi Eunhee S, Olivo-Marston Susan, Yang Ping, Harris Curtis |
- Page last reviewed:Oct 1, 2020
- Page last updated:Nov 27, 2020
- Content source: